Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Keirstinne Turcios et al.|Cell Reports|2021Cited by 266
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological ManifestationsBing Sun, Lynn Pulliam, Norina Tang et al.|Cells|2021Cited by 187
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Saki Takahashi et al.|Science Advances|2021Cited by 150
A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruptionMichael J. Peluso, Karine Dubé, Lynda Dee et al.|Journal of Virus Eradication|2020Cited by 54
A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infectionElizabeth McCarthy, Rachel L. Rutishauser|Cell Reports|2022Cited by 5